Polyspecific antibodies

· Xenothera SAS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Polyspecific antibodies, covering 2025-07-22 to 2025-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Polyspecific Antibodies in Lymphoproliferative T-cell Disorders [Phase 1, Phase 2]